• 1
    Bayram S, Sivrioglu K, Karli N, Ozcan O. (2006) Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: a preliminary study. Am J Phys Med Rehabil 85: 7581.
  • 2
    Francisco GE, Boake C, Vaughn A. (2002) Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques. Am J Phys Med Rehabil 81: 355363.
  • 3
    Koman LA, Brashear A, Rosenfeld S, Chambers H, Russman B, Rang M, Root L, Ferrari E, Garcia de Yebenes Prous J, Smith B P, et al. (2001) Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics 108: 10621071.
  • 4
    Chen R, Karp BI, Hallett M. (1998) Botulinum toxin type F for treatment of dystonia: long-term experience. Neurology 51: 14941496.
  • 5
    Dodd SL, Selsby J, Payne A, Judge A, Dott C. (2005) Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle. Toxicon 46: 196203.
  • 6
    Eleopra R, Tugnoli V, Caniatti L, De Grandis D. (1996) Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion. Neurology 46: 11581160.
  • 7
    Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C. (2005) A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurol Sci 26: 2631.
  • 8
    Hughes R, Whaler B. (1962) Influence of nerve-ending activity and of drugs on the rate or paralysis of rat diaphragm preparation by Cl. Botulinum type A toxin. J Physiol (London) 160: 221233.
  • 9
    Black JD, Dolly JO. (1986) Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol 103: 535544.
  • 10
    Frasson E, Priori A, Ruzzante B, Didone G, Bertolasi L. (2005) Nerve stimulation boosts botulinum toxin action in spasticity. Mov Disord 20: 624629.
  • 11
    Eleopra R, Tugnoli V, De Grandis D. (1997) The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord 12: 8994.
  • 12
    Chen R, Karp BI, Goldstein SR, Bara-Jimenez W, Yaseen Z, Hallett M. (1999) Effect of muscle activity immediately after botulinum toxin injection for writer's cramp. Mov Disord 14: 307312.
  • 13
    Peters D, Barash IA, Burdi M, Yuan PS, Mathew L, Fridén J, Lieber RL. (2003) Asynchronous functional, cellular and transcriptional changes after a bout of eccentric exercise in the rat. J Physiol (London) 553: 947957.
  • 14
    Hentzen E, Lahey M, Peters D, Mathew L, Barash I, Fridén J, Lieber R. (2006) Stress-dependent and stress-independent expression of the myogenic regulatory factors and the MARP genes after eccentric contractions. J Physiol (London) 570: 157167.
  • 15
    Weibel ER. (1979) Stereological Methods. Vol 1 - Practical Methods for Biological Morphometry. London : Academic Press. pp 962, 101–161.
  • 16
    Sokal RR, Rohlf FJ. (1981) Biometry. San Francisco : WH Freeman and Company.
  • 17
    Draper NR, Smith H. (1981) Applied Regression Analysis. New York : John Wiley &Sons.
  • 18
    Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, Chapman ER. (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312: 592596.
  • 19
    Kim HS, Hwang JH, Jeong ST, Lee PKW, Shim JSS. (2003) Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis. Dev Med Child Neurol 45: 200206.
  • 20
    Carda S, Molteni F. (2005) Taping versus electrical stimulation after botulinum toxin type A injection for wrist and finger spasticity. A case-control study. Clin Rehabil 19: 621626.
  • 21
    Molteni F. (1995) Botulinum toxin and rehabilitation programs in lower limb spasticity. Eur J Neurol 2: 6167.
  • 22
    Hesse S, Jahnke MT, Luecke D, Mauritz KH. (1995) Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 201: 3740.
  • 23
    De Paiva A, Meunier F, Molgó J, Aoki K, Dolly O. (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 96: 32003205.
  • 24
    Booth F W. (1982) Effect of limb immobilization on skeletal muscle. J Appl Physiol 52: 11131118.
  • 25
    Pattullo M, Cotter M, Cameron N, Barry J. (1992) Effects of lengthened immobilization on functional and histochemical properties of rabbit tibialis anterior muscle. Exp Physiol 77: 433442.
  • 26
    Caiozzo V, Haddad F, Baker M, Herrick R, Prietto N, Baldwin K. (1996) Microgravity-induced transformations of myosin isoforms and contractile properties of skeletal muscle. J Appl Physiol 81: 123132.
  • 27
    Roy R, Bello M, Bouissou P, Edgerton R. (1987) Size and metabolic properties of fibers in rat fast-twitch muscles after hindlimb suspension. J Appl Physiol 62: 23482357.
  • 28
    Mitch WE, Goldberg AL. (1996) Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335: 18971905.
  • 29
    Simard C P, Spector SA, Edgerton VR. (1982) Contractile properties of rat hindlimb muscles immobilized at different lengths. Exp Neurol 77: 467482.
  • 30
    Spector SA, Gardiner PF, Zernicke RF, Roy RR, Edgerton VR. (1980) Muscle architecture and force-velocity characteristics of the cat soleus and medial gastrocnemius: implications for motor control. J Neurophysiol 44: 951960.
  • 31
    Lieber RL, Steinman S, Barash IA, Chambers H. (2004) Structural and functional changes in spastic skeletal muscle. Muscle Nerve 29: 615627.
  • 32
    Wright J, Rang M. (1990) The spastic mouse. And the search for an animal model of spasticity in human beings. Clin Orthop Relat Res 253: 1219.
  • 33
    Wickiewicz TL, Roy RR, Powell PL, Edgerton VR. (1983) Muscle architecture of the human lower limb. Clin Orthop Rel Res 179: 275283.